Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Haleon PLC Sponsored ADR ( (HLN) ) has issued an update.
On September 10, 2025, Haleon PLC announced the purchase of 1,590,000 ordinary shares for cancellation as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, conducted on September 9, 2025, aims to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares with voting rights to 8,951,243,846. This strategic move may strengthen Haleon’s market position and reflect positively on its commitment to returning value to its shareholders.
The most recent analyst rating on (HLN) stock is a Hold with a $10.50 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.
Haleon PLC’s overall stock score reflects a strong financial foundation with robust cash flow and profitability margins. However, the lack of revenue growth and challenges in the North American market weigh on the score. Technical indicators and valuation suggest a stable but limited growth outlook, while the earnings call provides some optimism for international performance and operational improvements.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC Sponsored ADR
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company’s product portfolio includes Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.
Average Trading Volume: 11,224,080
Technical Sentiment Signal: Buy
Current Market Cap: $43.46B
Find detailed analytics on HLN stock on TipRanks’ Stock Analysis page.